CpG-Islands as Markers for Liquid Biopsies of Cancer Patients

The analysis of tumours using biomarkers in blood is transforming cancer diagnosis and therapy. Cancers are characterised by evolving genetic alterations, making it difficult to develop reliable and broadly applicable DNA-based biomarkers for liquid biopsy. In contrast to the variability in gene mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprang, Maximilian, Paret, Claudia, Faber, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465093/
https://www.ncbi.nlm.nih.gov/pubmed/32752173
http://dx.doi.org/10.3390/cells9081820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465093/
https://www.ncbi.nlm.nih.gov/pubmed/32752173
http://dx.doi.org/10.3390/cells9081820

Ejemplares similares